Nasullah Khalid-Alham

Nasullah Khalid-Alham

Auto-generated profile, based on publicly available information

Nasullah Khalid-Alham

Nuffield Department of Surgical Sciences, University of Oxford

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
MHMegat Abd Hamid
Megat Abd Hamid
HCHuw Colin-York
Huw Colin-York
NKNasullah Khalid-Alham
Nasullah Khalid-Alham
MBMolly Browne
Molly Browne
LCLucia Cerundolo
Lucia Cerundolo
TDTao Dong
Tao Dong
Enrichment of CD103+ tumor-infiltrating T lymphocytes (TIL) is associated with improved outcomes in patients. However, the characteristics of human CD103+ cytotoxic CD8+ T cells (CTL) and their role in tumor control remain unclear. We investigated the features and antitumor mechanisms of CD103+ CTLs by assessing T-cell receptor (TCR)–matched CD103+ and CD103− cancer-specific CTL immunity in vitro and its immunophenotype ex vivo. Interestingly, we found that differentiated CD103+ cancer-specific CTLs expressed the active form of TGFβ1 to continually self-regulate CD103 expression, without relying on external TGFβ1-producing cells. The presence of CD103 on CTLs improved TCR antigen sensitivity, which enabled faster cancer recognition and rapid antitumor cytotoxicity. These CD103+ CTLs had elevated energetic potential and faster migration capacity. However, they had increased inhibitory receptor coexpression and elevated T-cell apoptosis following prolonged cancer exposure. Our data provide fundamental insights into the properties of matured human CD103+ cancer-specific CTLs, which could have important implications for future designs of tissue-localized cancer immunotherapy strategies.

31 October 2012 in Neural Computing and Applications
Verified
Journal Article
Closed access
PDF file
NANasullah Khalid Alham
Nasullah Khalid Alham
Maozhen LiMaozhen Li
Maozhen Li
Yang LiuYang Liu
Yang Liu

1 July 2011
Verified
Conference Paper
Closed access
Yang LiuYang Liu
Yang Liu
Maozhen LiMaozhen Li
Maozhen Li
NANasullah Khalid Alham
Nasullah Khalid Alham
SHSuhel Hammoud
Suhel Hammoud
MPMahesh Ponraj
Mahesh Ponraj
The distributed computations are widely used in the modern world for processing large scale jobs. Hadoop framework which is based on Google MapReduce model becomes popular due to its great processing power and ease to use. However, due to lack of load management, especially in a heterogeneous computing environment, the performance of Hadoop framework may be deteriorated. Therefore this paper presents a load balancing algorithm which aims to balance the load among heterogeneous nodes. And also, the Hadoop simulator HSim is involved to evaluate the performance of the load balancing algorithm. The results indicate that the performance of the cluster has been significantly enhanced.

1 August 2010
Verified
Conference Paper
Closed access
NANasullah Khalid Alham
Nasullah Khalid Alham
Maozhen LiMaozhen Li
Maozhen Li
SHSuhel Hammoud
Suhel Hammoud
Yang LiuYang Liu
Yang Liu
MPMahesh Ponraj
Mahesh Ponraj
The popularity of SVMs has grown tremendously in the last few years for many different classification problems due to its generalization properties, however training SVMs require high computational power. Platt's SMO is one the fastest algorithm for training support vector machines, which takes the decomposition technique to the extreme by selecting a set of only two points as the working set then solving them analytically. However SMO becomes slow for large size training data set. In this paper we present a MapReduce based distributed implementation of SMO using Hadoop. The distributed SMO uses multiple core processors to process the training data. By partitioning the training data set into smaller subsets and allocating each of the partitioned subsets to a single Map task, each Map task optimizes the partition in parallel and finally the reducer combine the results. Experiments show the efficiency of the distributed SMO increases with the increase of the number of processors, the training speed of distributed SMO with 12 Map task is about 11times higher than standalone SMO. There is no significant difference in accuracy between distributed and standalone SMO.

27 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSrinivasa Rao
Srinivasa Rao
CVClare Verrill
Clare Verrill
LCLucia Cerundolo
Lucia Cerundolo
NANasullah Khalid Alham
Nasullah Khalid Alham
ZKZeynep Kaya
Zeynep Kaya
FHFreddie C. Hamdy
Freddie C. Hamdy
Extension of prostate cancer beyond the primary site into the surrounding organs by local invasion or nodal metastasis is associated with poor prognosis. The emergence and evolution of cancer clones at this early stage of expansion and spread has not been studied in detail. We performed whole genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and regional lymph nodes of five treatment-naive patients with locally advanced disease who underwent radical prostatectomy. Using cancer cell fractions computed from single nucleotide variants and copy number alterations, we reconstructed the tumour phylogenies, which in turn allowed us to infer key molecular steps in the progression of prostate cancer in these individuals. We mapped the clonal composition of cancer sampled across the prostate in each individual and inferred the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes. Based on these data, we delineated the route of tumour progression and metastasis following the transformation of adenocarcinoma to amphicrine morphology, the molecular events leading to whole genome duplication associated with a single clonal expansion and identified putative driver events associated with local invasion and lymph node metastasis. We also correlated genomic changes associated with differences in morphology and identified putative driver events associated with spread to seminal vesicle invasion and lymph node metastasis. Taken together, these findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes associated with morphological transformation. Our results demonstrate the value of integrating multi-region sequencing with histopathological data to study tumour evolution and identify mechanisms of prostate cancer spread.

23 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ACAndrea Chatrian
Andrea Chatrian
RCRichard Colling
Richard Colling
LBLisa Browning
Lisa Browning
NANasullah Khalid Alham
Nasullah Khalid Alham
KSKorsuk Sirinukunwattana
Korsuk Sirinukunwattana
CVClare Verrill
Clare Verrill
The use of immunohistochemistry in the reporting of prostate biopsies is an important adjunct when the diagnosis is not definite on haematoxylin and eosin (H&E) morphology alone. The process is however inherently inefficient with delays while waiting for pathologist review to make the request and duplicated effort reviewing a case more than once. In this study, we aimed to capture the workflow implications of immunohistochemistry requests and demonstrate a novel artificial intelligence tool to identify cases in which immunohistochemistry (IHC) is required and generate an automated request. We conducted audits of the workflow for prostate biopsies in order to understand the potential implications of automated immunohistochemistry requesting and collected prospective cases to train a deep neural network algorithm to detect tissue regions that presented ambiguous morphology on whole slide images. These ambiguous foci were selected on the basis of the pathologist requesting immunohistochemistry to aid diagnosis. A gradient boosted trees classifier was then used to make a slide level prediction based on the outputs of the neural network prediction. The algorithm was trained on annotations of 219 immunohistochemistry-requested and 80 control images, and tested by 3-fold cross-validation. Validation was conducted on a separate validation dataset of 212 images. Non IHC-requested cases were diagnosed in 17.9 minutes on average, while IHC-requested cases took 33.4 minutes over multiple reporting sessions. We estimated 11 minutes could be saved on average per case by automated IHC requesting, by removing duplication of effort. The tool attained 99% accuracy and 0.99 Area Under the Curve (AUC) on the test data. In the validation, the average agreement with pathologists was 0.81, with a mean AUC of 0.80. We demonstrate the proof-of-principle that an AI tool making automated immunohistochemistry requests could create a significantly leaner workflow and result in pathologist time savings.